VIII Multidyscyplinarna Konferencja Nauki o Leku

 on-line journal

Presenting person

May 30th, Wednesday

09:00 00:45:00 Invited oral Janusz Obukowicz Pharmaceutical  technologies  – why do they have to be innovative
09:45 00:45:00 Invited oral Jerzy Boryski Pyrimidine nucleoside analogues with appended heterocylic ring and their antiviral properties
10:50 00:45:00 Invited oral Aleksander P. Mazurek Nanotechnolgy in pharmacy and medicine – contemporary status and future perspectives
11:35 00:20:00 Oral Ewa B. Bębenek Synthesis and anticancer activity of acetylenic derivatives of betulin
11:55 00:20:00 Oral Ewelina M. Błońska-Sikora The influence of crenotherapy on glutathione level in human body.
12:15 00:20:00 Oral Teresa M. Brodniewicz Plant phenolics as new drug leads. What’s missing?  
12:35 00:20:00 Oral Tomasz Rzymski SEL-120-small molecule CDK8/9 kinase inhibitors as potential targeted therapy in colorectal cancer treatment.
14:30 00:45:00 Invited oral Jerzy Ostrowski Molecular medicine - Facts and myths
15:15 00:20:00 Oral Marcin Gawryś Impurity profiling using 2D-HPLC-IT-TOF
15:35 00:20:00 Oral Katarzyna E. Filip Genotoxic impurities in pharmaceuticals
15:55 00:20:00 Oral Marek Wasek The analysis of plant-based raw materials of the unknown origin
16:15 00:20:00 Oral Maciej Serda Iron chelators- the novel perspective in cancer treatment

May 31st, Thursday

09:00 00:45:00 Invited oral Matthias Bochtler The link between CpG methylation and depletion and a new CpG specific methyltransferase
10:50 00:45:00 Invited oral Zbigniew J. Leśnikowski New trends in search for bioactive compounds: EU-OPENSCREEN and boron clusters.
11:35 00:20:00 Oral Maria Puchalska Development and validation of HPLC method. Review of selected cases.
11:55 00:20:00 Oral Monika Lamparska-Przybysz CPL-200-075, a novel potent renal sodium-glucose cotransporter 2 (SGLT2) inhibitor
12:15 00:20:00 Oral Kamil K. Kamiński Dextran-based materials reducing anticoagulant activity of heparin in animal models in vitro and in vivo
12:35 00:20:00 Oral Robert Musiol Quinoline based antifungals
14:30 00:45:00 Invited oral Stefan Chłopicki Experimental pharmacology of endothelium: MNA/COX-2/PGI2 pathway
15:15 00:20:00 Oral Zofia Lipkowska Supramolecular assembly and properties of dendrimeric peptide mimics
15:35 00:20:00 Oral Dorota Maciejewska The molecularly imprinted polymers as selective  sorbents to pharmaceutical analyses
15:55 00:20:00 Oral Katarzyna Sidoryk Synthesis and biological evaluation of new amino acid and dipeptide derivatives of neocryptolepine as anticancer agents. 
16:15 00:20:00 Oral Filip Stefaniak Design and development of CPL-407-22 – novel, potent and selective JAK2 protein kinase inhibitor.

June 1st, Friday

08:40 00:20:00 Oral Ryszard Ostaszewski Studies toward Novel Peptidomimetc Inhibitors of Thioredoxin-Thiredoxin Reductase System
09:00 00:45:00 Invited oral Wiesław Szeja Sugars in new drug design. Sugar moiety structure as a principal determinant of antitumor glycoconjugates biological activity.
09:45 00:45:00 Invited oral Mariusz Kondrat Legal protection of borderline products in reference to food supplements and pharmaceuticals.
10:50 00:45:00 Invited oral Lech Kozerski Molecular complexes of topo I and II inhibitors from camptothecin and flavonoid families with model DNA oligomers. Search for sequence specific binding. Verification of biological assays on atomic coordinates level. 
11:35 00:45:00 Invited oral Bartłomiej Furman Diastereoselective Synthesis of β-Lactams via Kinugasa Reaction
12:20 00:20:00 Oral Michał Fedoryński Synthesis of trans-4-cyclohexyl-(S)-proline - an intermediate in Fosinopril process
12:40 00:20:00 Oral Anita Płazińska Differential aspects of molecular interactions fenoterol stereoisomers and derivatives with the β2-adrenergic receptor
14:30 00:45:00 Invited oral Piotr Pawluć Application of the Silylative Coupling Reaction in Organic Synthesis
15:15 00:20:00 Oral Elżbieta Hejchman Synthesis and anticancer properties of coumarin gallates
15:35 00:20:00 Oral Katarzyna Wiktorska Sulforaphane - a modulator of detoxifying enzymes can alter medicines effectiveness.
15:55 00:20:00 Oral Anna Mrozek-Wilczkiewicz Studies on anticancer iron chelators
16:15 00:20:00 Oral Piotr J. Rudzki Validation of bioanalytical methods according to new European Medicines Agency guideline
16:35 00:20:00 Oral Andrzej Kutner A novel convergent synthesis of the prostaglandin F analogues
© 1998-2024 pielaszek research, all rights reserved Powered by the Conference Engine